Cell line name |
Jurkat E6.1 NF-kappaB::eGFP |
Accession |
CVCL_WN96 |
Resource Identification Initiative |
To cite this cell line use: Jurkat E6.1 NF-kappaB::eGFP (RRID:CVCL_WN96) |
Comments |
Population: Caucasian. Characteristics: The eGFP reporter gene is under control of a NF-kappaB promoter element. Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP). Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Cell type: T-cell; CL=CL_0000084. |
Sequence variations |
- Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; 11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
|
Disease |
Childhood T acute lymphoblastic leukemia (NCIt: C7953) Precursor T-cell acute lymphoblastic leukemia (ORDO: Orphanet_99861) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Hierarchy |
Parent: CVCL_0367 (Jurkat E6.1) Children:
|
Sex of cell |
Male |
Age at sampling |
14Y |
Category |
Cancer cell line |
Publications | PubMed=25500904; DOI=10.1038/srep07438; PMCID=PMC4262884 Ratzinger F., Haslacher H., Poeppl W., Hoermann G., Kovarik J.J., Jutz S., Steinberger P., Burgmann H., Pickl W.F., Schmetterer K.G. Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity. Sci. Rep. 4:7438-7438(2014) PubMed=29029399; DOI=10.18632/oncotarget.17615; PMCID=PMC5630299 Jutz S., Hennig A., Paster W., Asrak O., Dijanovic D., Kellner F., Pickl W.F., Huppa J.B., Leitner J., Steinberger P. A cellular platform for the evaluation of immune checkpoint molecules. Oncotarget 8:64892-64906(2017) PubMed=31092850; DOI=10.1038/s41598-019-43529-4; PMCID=PMC6520406 Humeniuk P., Geiselhart S., Battin C., Webb T.J., Steinberger P., Paster W., Hoffmann-Sommergruber K. Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Sci. Rep. 9:7426-7426(2019) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_WN96
|
Encyclopedic resources |
Wikidata; Q94332818
|
Entry history |
Entry creation | 05-Jul-2019 |
Last entry update | 10-Sep-2024 |
Version number | 11 |
---|